Attention: This platform is in beta mode. Expect some changes and adjustments.

AI Market Mood: Stock Dashboard

BLCO


Fundamental

Company: Bausch + Lomb Corp
Sector: Healthcare
Industry: Medical Instruments & Supplies
Country: Canada
Exchange: NYSE
Index: -
P/E: -
EPS (ttm): -1.02
Insider Own: 89.29%
Shs Outstand: 354.21M
Perf Week: -0.70%
Market Cap: 5.53B
Forward P/E: 14.62
EPS next Y: 1.07
Insider Trans: 0.02%
Shs Float: 37.94M
Perf Month: -15.58%
Enterprise Value: 10.45B
PEG: 0.37
EPS next Q: 0.05
Inst Own: 10.56%
Short Float: 10.56%
Perf Quarter: -8.23%
Income: -360.00M
P/S: 1.08
EPS this Y: 52.76%
Inst Trans: -0.84%
Short Ratio: 9.85
Perf Half Y: 8.63%
Sales: 5.10B
P/B: 0.86
EPS next Y Percentage: 37.05%
ROA: -2.62%
Short Interest: 4.01M
Perf YTD: -8.61%
Book/sh: 18.20
P/C: 13.93
EPS next 5Y: 39.78%
ROE: -5.57%
52W High: 18.92 -17.47%
Perf Year: 4.07%
Cash/sh: 1.12
P/FCF: -
EPS past 3/5Y: - -
ROIC: -3.10%
52W Low: 10.45 49.38%
Perf 3Y: -4.58%
Dividend Est.: -
EV/EBITDA: 17.16
Sales past 3/5Y: 10.62% 8.38%
Gross Margin: 54.75%
Volatility W: 3.05%
Volatility M: 3.18%
Perf 5Y: -
Dividend TTM: -
EV/Sales: 2.05
EPS Y/Y TTM: -12.96%
Oper. Margin: 3.69%
ATR (14): 0.56
Perf 10Y: -
Dividend Ex-Date: -
Quick Ratio: 1.04
Sales Y/Y TTM: 6.47%
Profit Margin: -7.06%
RSI (14): 36.01
Recom: 2.71
Dividend Gr. 3/5Y: - -
Current Ratio: 1.55
EPS Q/Q: -1825.88%
SMA20: -6.50%
Beta: 0.66
Target Price: 18.46
Payout: -
Debt/Eq: 0.81
Sales Q/Q: 9.77%
SMA50: -8.35%
Rel Volume: 0.60
Prev Close: 15.89
Employees: 13000
LT Debt/Eq: 0.80
Earnings: Feb 18 BMO
SMA200: 0.66%
Avg Volume: 406.68K
Price: 15.61
IPO: May 06, 2022
Option/Short: Yes / Yes
EPS/Sales Surpr.: -9.91% 1.42%
Trades:
Volume: 72,393
Change: -1.76%

Technical:


Latest News:

Analysts Offer Insights on Healthcare Companies: Amgen (AMGN) and Bausch + Lomb ... very bullish
AMGN BLCO

Summary: Analysts have expressed bullish sentiments on Amgen (AMGN) and Bausch + Lomb Corporation (BLCO) in the Healthcare sector. Wells Fargo analyst maintained a Buy rating on both companies, setting price targets of $320.00 for Amgen and $23.00 for BLCO. The consensus ratings for these stocks suggest potential upsides of 14.1% and 31.5% respectively.

Full article
2024-04-24T20:31:52Z